4.7 Article

Genetic and Functional Studies Implicate HIF1α as a 14q Kidney Cancer Suppressor Gene

期刊

CANCER DISCOVERY
卷 1, 期 3, 页码 222-235

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-11-0098

关键词

-

类别

资金

  1. NIH
  2. Howard Hughes Medical Institute
  3. Doris Duke Charitable Foundation
  4. Dana-Farber/Harvard Cancer Center
  5. Genentech

向作者/读者索取更多资源

Kidney cancers often delete chromosome 3p, spanning the VHL tumor suppressor gene, and chromosome 14q, which presumably harbors >= 1 tumor suppressor genes. pVHL inhibits the hypoxia-inducible transcription factor (HIF), and HIF2 alpha is a kidney cancer oncoprotein. In this article, we identify focal, homozygous deletions of the HIF1 alpha locus on 14q in clear cell renal carcinoma cell lines. Wild-type HIF1 alpha suppresses renal carcinoma growth, but the products of these altered loci do not. Conversely, downregulation of HIF1 alpha in HIF1 alpha-proficient lines promotes tumor growth. HIF1a activity is diminished in 14q-deleted kidney cancers, and all somatic HIF1 alpha mutations identified in kidney cancers tested to date are loss of function. Therefore, HIF1 alpha has the credentials of a kidney cancer suppressor gene. SIGNIFICANCE: Deletion of 14q is a frequent event in clear cell renal carcinoma and portends a poor prognosis. In this study, we provide genetic and functional evidence that HIF1 alpha is a target of 14q loss in kidney cancer. Cancer Discovery; 1(3);222-35. (C) 2011 AACR.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据